Author response for 'Pembrolizumab for refractory primary mediastinal B‐cell lymphoma with central nervous system involvement'

Authors :: Cristina de-la-Fuente
Juan-Manuel Sancho
Montserrat Cortes-Romera
Josep-Maria Ribera
Mireia Franch-Sarto
Fidel Nuñez
Publication Year :: 2020
Publisher :: Wiley, 2020.

Subjects :: Pathology
medicine.medical_specialty
medicine.anatomical_structure
Refractory
business.industry
Central nervous system
medicine
Pembrolizumab
Primary mediastinal B-cell lymphoma
medicine.disease
business

Full Text Access

Tools